Free Trial
NASDAQ:ASMB

Assembly Biosciences (ASMB) Stock Price, News & Analysis

Assembly Biosciences logo
$21.22 +1.79 (+9.21%)
Closing price 08/7/2025 04:00 PM Eastern
Extended Trading
$21.22 +0.01 (+0.02%)
As of 08/7/2025 04:39 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

About Assembly Biosciences Stock (NASDAQ:ASMB)

Key Stats

Today's Range
$19.13
$22.50
50-Day Range
$14.26
$21.22
52-Week Range
$7.75
$22.50
Volume
145,350 shs
Average Volume
31,878 shs
Market Capitalization
$162.08 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$33.00
Consensus Rating
Moderate Buy

Company Overview

Assembly Biosciences Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
76th Percentile Overall Score

ASMB MarketRank™: 

Assembly Biosciences scored higher than 76% of companies evaluated by MarketBeat, and ranked 230th out of 921 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Assembly Biosciences has received a consensus rating of Moderate Buy. The company's average rating score is 2.67, and is based on 2 buy ratings, 1 hold rating, and no sell ratings.

  • Amount of Analyst Coverage

    Assembly Biosciences has received no research coverage in the past 90 days.

  • Read more about Assembly Biosciences' stock forecast and price target.
  • Earnings Growth

    Earnings for Assembly Biosciences are expected to decrease in the coming year, from ($6.87) to ($7.64) per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Assembly Biosciences is -3.80, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Assembly Biosciences is -3.80, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Book Value per Share Ratio

    Assembly Biosciences has a P/B Ratio of 4.04. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

  • Read more about Assembly Biosciences' valuation and earnings.
  • Percentage of Shares Shorted

    0.76% of the float of Assembly Biosciences has been sold short.
  • Short Interest Ratio / Days to Cover

    Assembly Biosciences has a short interest ratio ("days to cover") of 1.1, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Assembly Biosciences has recently increased by 0.33%, indicating that investor sentiment is decreasing.
  • Dividend Yield

    Assembly Biosciences does not currently pay a dividend.

  • Dividend Growth

    Assembly Biosciences does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    0.76% of the float of Assembly Biosciences has been sold short.
  • Short Interest Ratio / Days to Cover

    Assembly Biosciences has a short interest ratio ("days to cover") of 1.1, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Assembly Biosciences has recently increased by 0.33%, indicating that investor sentiment is decreasing.
  • News Sentiment

    Assembly Biosciences has a news sentiment score of 0.68. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.39 average news sentiment score of Medical companies.
  • News Coverage This Week

    MarketBeat has tracked 6 news articles for Assembly Biosciences this week, compared to 5 articles on an average week.
  • MarketBeat Follows

    3 people have added Assembly Biosciences to their MarketBeat watchlist in the last 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, Assembly Biosciences insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    Only 5.30% of the stock of Assembly Biosciences is held by insiders.

  • Percentage Held by Institutions

    Only 19.92% of the stock of Assembly Biosciences is held by institutions.

  • Read more about Assembly Biosciences' insider trading history.
Receive ASMB Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Assembly Biosciences and its competitors with MarketBeat's FREE daily newsletter.

ASMB Stock News Headlines

Assembly Biosciences (ASMB) Expected to Announce Earnings on Thursday
Critical AI announcement set to ignite AI 2.0
Markets are jittery. Rallies fade. Sectors rotate overnight. And the true impact of new tariffs and policy shifts hasn’t even hit the data yet. That’s why smart traders are turning to a strategy built for exactly this kind of market—fast, simple, and designed to react to real price action, not predictions.
See More Headlines

ASMB Stock Analysis - Frequently Asked Questions

Assembly Biosciences' stock was trading at $15.78 on January 1st, 2025. Since then, ASMB shares have increased by 34.5% and is now trading at $21.22.

Assembly Biosciences, Inc. (NASDAQ:ASMB) announced its earnings results on Wednesday, August, 6th. The biopharmaceutical company reported ($1.33) earnings per share (EPS) for the quarter, topping analysts' consensus estimates of ($1.73) by $0.40. The biopharmaceutical company had revenue of $9.63 million for the quarter, compared to analyst estimates of $5.30 million. Assembly Biosciences had a negative trailing twelve-month return on equity of 135.14% and a negative net margin of 117.20%.

Assembly Biosciences's stock reverse split on Monday, February 12th 2024.The 1-12 reverse split was announced on Monday, February 12th 2024. The number of shares owned by shareholders was adjusted after the market closes on Monday, February 12th 2024. An investor that had 100 shares of stock prior to the reverse split would have 8 shares after the split.

Top institutional shareholders of Assembly Biosciences include Palumbo Wealth Management LLC (0.24%). Insiders that own company stock include Alexander Schornstein, John G Mchutchison, Jason A Okazaki, Nicole S White, Jeanette M Bjorkquist and Michael Houghton.
View institutional ownership trends
.

Shares of ASMB stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Assembly Biosciences investors own include Waste Connections (WCN), Voyager Therapeutics (VYGR), DiamondRock Hospitality (DRH), AU Optronics (AUOTY), American Water Works (AWK), The RMR Group (RMR) and iShares Micro-Cap ETF (IWC).

Company Calendar

Last Earnings
8/06/2025
Today
8/07/2025
Next Earnings (Estimated)
8/14/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
MED - GENERIC DRG
Sub-Industry
Pharmaceuticals
Current Symbol
NASDAQ:ASMB
CIK
1426800
Employees
100
Year Founded
2005

Price Target and Rating

High Price Target
$35.00
Low Price Target
$31.00
Potential Upside/Downside
+55.5%
Consensus Rating
Moderate Buy
Rating Score (0-4)
2.67
Research Coverage
3 Analysts

Profitability

EPS (Trailing Twelve Months)
($6.23)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$40.18 million
Net Margins
-117.20%
Pretax Margin
-123.12%
Return on Equity
-135.14%
Return on Assets
-36.71%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
2.05
Quick Ratio
2.05

Sales & Book Value

Annual Sales
$28.52 million
Price / Sales
5.68
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$5.25 per share
Price / Book
4.04

Miscellaneous

Outstanding Shares
7,640,000
Free Float
7,233,000
Market Cap
$162.12 million
Optionable
Optionable
Beta
0.64

Social Links

10 Stocks Set to Soar in Fall 2025 Cover

Enter your email address and we'll send you MarketBeat's list of ten stocks that are set to soar in Fall 2025, despite the threat of tariffs and other economic uncertainty. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.

Get This Free Report

This page (NASDAQ:ASMB) was last updated on 8/8/2025 by MarketBeat.com Staff
From Our Partners